Suppr超能文献

相似文献

1
Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
Int J Pharm. 2015 Nov 10;495(1):312-317. doi: 10.1016/j.ijpharm.2015.08.101. Epub 2015 Sep 1.
2
Early drug development predictions of glass-forming ability and physical stability of drugs.
Eur J Pharm Sci. 2013 May 13;49(2):323-32. doi: 10.1016/j.ejps.2013.03.016. Epub 2013 Apr 2.
4
Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
J Pharm Sci. 2019 Aug;108(8):2561-2569. doi: 10.1016/j.xphs.2019.02.028. Epub 2019 Mar 13.
6
Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
Mol Pharm. 2008 Nov-Dec;5(6):927-36. doi: 10.1021/mp800169g.
7
Glass-forming ability of compounds in marketed amorphous drug products.
Eur J Pharm Biopharm. 2017 Mar;112:204-208. doi: 10.1016/j.ejpb.2016.11.031. Epub 2016 Nov 27.
9
Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Int J Pharm. 2015 Jul 25;490(1-2):248-57. doi: 10.1016/j.ijpharm.2015.05.036. Epub 2015 May 21.
10
Influence of preparation pathway on the glass forming ability.
Int J Pharm. 2017 Apr 15;521(1-2):232-238. doi: 10.1016/j.ijpharm.2017.02.042. Epub 2017 Feb 21.

引用本文的文献

1
Glassy Drug Microneedle Array Design: Drug Glass-Forming Ability and Stability.
Mol Pharm. 2025 Mar 3;22(3):1373-1383. doi: 10.1021/acs.molpharmaceut.4c01067. Epub 2025 Feb 16.
2
Stability of Ternary Drug-Drug-Drug Coamorphous Systems Obtained Through Mechanochemistry.
Pharmaceutics. 2025 Jan 12;17(1):92. doi: 10.3390/pharmaceutics17010092.
3
High-Throughput Microarray Approaches for Predicting the Stability of Drug-Polymer Solid Dispersions.
Mol Pharm. 2025 Jan 6;22(1):343-362. doi: 10.1021/acs.molpharmaceut.4c00955. Epub 2024 Dec 21.
4
Computational Support to Explore Ternary Solid Dispersions of Challenging Drugs Using Coformer and Hydroxypropyl Cellulose.
Mol Pharm. 2024 Nov 4;21(11):5619-5631. doi: 10.1021/acs.molpharmaceut.4c00592. Epub 2024 Oct 10.
7
Controlling the Polymorphism of Indomethacin with Poloxamer 407 in a Gas Antisolvent Crystallization Process.
ACS Omega. 2022 Nov 18;7(48):43945-43957. doi: 10.1021/acsomega.2c05259. eCollection 2022 Dec 6.

本文引用的文献

1
Experimental and computational prediction of glass transition temperature of drugs.
J Chem Inf Model. 2014 Dec 22;54(12):3396-403. doi: 10.1021/ci5004834. Epub 2014 Dec 1.
3
Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
J Phys Chem B. 2014 Aug 21;118(33):9974-82. doi: 10.1021/jp504450h. Epub 2014 Aug 7.
4
Computational predictions of glass-forming ability and crystallization tendency of drug molecules.
Mol Pharm. 2014 Sep 2;11(9):3123-32. doi: 10.1021/mp500303a. Epub 2014 Jul 30.
6
Exploring the structure-aromaticity relationship in Hückel and Möbius N-fused pentaphyrins using DFT.
Phys Chem Chem Phys. 2014 Jul 28;16(28):14396-407. doi: 10.1039/c3cp55509g.
7
Data mining of solubility parameters for computational prediction of drug-excipient miscibility.
Drug Dev Ind Pharm. 2014 Jul;40(7):904-9. doi: 10.3109/03639045.2013.789906. Epub 2013 Apr 29.
8
Early drug development predictions of glass-forming ability and physical stability of drugs.
Eur J Pharm Sci. 2013 May 13;49(2):323-32. doi: 10.1016/j.ejps.2013.03.016. Epub 2013 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验